30 November 2020

HOVON Alert for eligibility in HOVON trials

Dear HOVON PIs and Site Principal Investigators,

Recently there have been some issues and debate about eligibility of patients for a trial, specifically in situations where there seems to be a discrepancy between the protocol criteria and regular medical practice. With this ALERT HOVON will clarify their policy on this point and provide best practice guidelines for both Site PIs participating in HOVON trials and Principal Investigators initiating HOVON trials.

 Please find this HOVON Alert here